Syros Pharmaceuticals, Inc.

NASDAQ:SYRS

0.209 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Omzet 0000.3863.7622.8332.954-5.4673.8916.2765.4677.8025.6975.1624.8275.6993.8283.1882.3790.5080.5580.4620.4540.8930.4120.3750.370001.1010.317000000.31700
Kosten van de omzet 0.3250.3310.3340.2790.6160.6530.7040.770.7240.7260.74700000000000000000000000000000
Brutowinst -0.325-0.331-0.3340.1073.1462.182.25-6.2373.1675.554.727.8025.6975.1624.8275.6993.8283.1882.3790.5080.5580.4620.4540.8930.4120.3750.370001.1010.317000000.31700
Brutowinstmarge 0000.2770.8360.770.7621.1410.8140.8840.86311111111111111110001100000100
Onderzoek- en ontwikkelingskosten 20.52721.62224.32121.22428.2829.60828.76127.91425.75933.125.17126.79527.26225.78620.02929.02617.67414.79614.56914.27715.93115.47512.56215.12812.85611.08211.11611.7810.44710.0419.6288.44311.5849.5258.2658.3786.8665.4283.7363.022
Algemene en administratieve kosten 5.6555.4636.2665.8887.7647.2257.4057.3298.0766.9456.9496.435.3465.525.7395.8925.1515.1335.1496.4015.0165.1954.8654.3723.8763.8414.0753.743.5933.4723.0862.9192.6332.542.3712.3111.5980.9840.8360.669
Verkoop- en marketingkosten 0000000000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 5.6555.4636.2665.8887.7647.2257.4057.3298.0766.9456.9496.435.3465.525.7395.8925.1515.1335.1496.4015.0165.1954.8654.3723.8763.8414.0753.743.5933.4723.0862.9192.6332.542.3712.3111.5980.9840.8360.669
Overige kosten 0-21.95300.1352.354009.51-9.510000000-0.489-0.4550.1130.4410.5960.7530.5120.5750.5830.5010.3580.2180.2150.1450.0980.080.0480.0440.04800-0.0020.0040
Bedrijfskosten 26.18227.08530.58727.11238.39836.83336.16635.24333.83540.04532.1233.22532.60831.30625.76834.91822.82519.92919.71820.67820.94720.6717.42719.516.73214.92315.19115.5214.0413.51312.71411.36214.21712.06510.63610.6898.4646.4124.5723.693
Bedrijfsresultaat -26.182-27.416-30.921-27.005-34.636-34-33.212-35.997-39.454-33.769-26.653-25.423-26.911-26.144-20.941-29.219-18.997-16.741-17.339-20.17-20.389-20.208-16.973-18.607-16.32-14.548-14.821-15.52-14.04-13.513-11.613-11.045-14.217-12.065-10.636-10.689-8.464-6.095-4.572-3.691
Bedrijfsresultaat ratio 000-69.961-9.207-12.001-11.2436.584-10.14-5.381-4.875-3.259-4.724-5.065-4.338-5.127-4.963-5.251-7.288-39.705-36.539-43.74-37.385-20.837-39.612-38.795-40.057000-10.548-34.84200000-19.22700
Totaal overige inkomsten en kosten netto 19.7864.08927.213-37.244-5.507-2.2589.42331.2239.201-0.7121.5071.610.8843.6546.713-0.911-0.489-0.4550.1130.4410.5960.7530.5120.5750.5830.5010.3580.2180.2150.1450.0980.080.0480.0440.04800-0.0020.0040.002
Inkomen voor belasting -6.396-23.327-3.708-64.384-40.143-36.258-23.789-4.774-30.253-34.481-25.146-23.813-26.027-22.49-14.228-30.13-19.486-17.196-17.226-19.729-19.793-19.455-16.461-18.032-15.737-14.047-14.463-15.302-13.825-13.368-11.515-10.965-14.169-12.021-10.588-10.689-8.464-6.097-4.568-3.689
Inkomen voor belasting ratio 000-166.798-10.671-12.798-8.0530.873-7.775-5.494-4.6-3.052-4.569-4.357-2.948-5.287-5.09-5.394-7.241-38.837-35.471-42.11-36.258-20.193-38.197-37.459-39.089000-10.459-34.5900000-19.23300
Belastingkosten 000.29110.883-3.2961.278-8.865-32.349-9.2010.712-1.5070.9860.9840.9690.9671.41700000000000-0.39000000000001.137
Nettowinst -6.396-23.327-3.708-64.384-40.143-36.258-14.92427.575-21.052-35.193-23.639-23.813-26.027-22.49-14.228-30.13-19.486-17.196-17.226-19.729-19.793-19.455-16.461-18.032-15.737-14.047-14.463-15.302-13.825-13.368-11.515-10.965-14.169-12.021-10.588-10.689-8.464-6.097-4.568-4.826
Nettowinstmarge 000-166.798-10.671-12.798-5.052-5.044-5.41-5.608-4.324-3.052-4.569-4.357-2.948-5.287-5.09-5.394-7.241-38.837-35.471-42.11-36.258-20.193-38.197-37.459-39.089000-10.459-34.5900000-19.23300
WPA (Winst Per Aandeel) -0.16-0.59-0.095-2.18-1.43-1.3-0.540.99-2.24-5.51-3.75-3.78-4.14-3.6-2.32-4.91-4.26-3.76-3.92-4.6-4.66-4.67-4.87-5.35-4.68-4.27-4.77-5.81-5.26-5.23-4.92-4.69-6.44-47.08-4.65-5.96-33.15-23.88-2.55-29.78
Verwaterde WPA -0.16-0.59-0.095-2.18-1.43-1.3-0.540.99-2.24-5.51-3.75-3.78-4.14-3.58-2.32-4.91-4.26-3.76-3.92-4.49-4.66-4.67-4.87-5.34-4.68-4.27-4.77-5.81-5.26-5.23-4.92-4.69-6.44-47.08-4.65-5.96-33.15-23.88-2.55-29.78
EBITDA -4.759-21.614-2.067-62.776-38.224-34.327-21.868-2.877-28.478-32.774-23.423-22.054-24.276-20.772-12.53-28.451-18.23-15.984-16.483-19.272-19.746-19.559-16.441-18.175-15.912-14.172-14.433-15.13-13.649-13.132-11.248-10.707-13.902-11.749-10.332-10.46-8.275-5.985-4.498-3.62
EBITDA ratio 000-69.238-9.207-11.022-10.4266.152-9.853-5.247-4.732-3.155-4.584-4.917-4.185-4.983-4.762-5.014-6.976-37.937-35.387-42.335-36.214-20.353-38.621-37.792-39.008000-10.216-33.77600000-18.8800